*** TEST ***
Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care – updates at the 2023 plenary event

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
828kB

Item Type:Review
Title:The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care – updates at the 2023 plenary event
Creators Name:Zaratin, P., Samadzadeh, S., Seferoğlu, M., Ricigliano, V., Dos Santos Silva, J., Tunc, A., Brichetto, G., Coetzee, T., Helme, A., Khan, U., McBurney, R., Peryer, G., Weiland, H., Baneke, P., Battaglia, M.A., Block, V., Capezzuto, L., Carment, L., Cortesi, P.A., Cutter, G., Leocani, L., Hartung, H.P., Hillert, J., Hobart, J., Immonen, K., Kamudoni, P., Middleton, R., Moghames, P., Montalban, X., Peeters, L., Sormani, M.P., van Tonder, S., White, A., Comi, G. and Vermersch, P.
Abstract:Significant advancements have been achieved in delineating the progress of the Global PROMS (PROMS) Initiative. The PROMS Initiative, a collaborative endeavor by the European Charcot Foundation and the Multiple Sclerosis International Federation, strives to amplify the influence of patient input on MS care and establish a cohesive perspective on Patient-Reported Outcomes (PROs) for diverse stakeholders. This initiative has established an expansive, participatory governance framework launching four dedicated working groups that have made substantive contributions to research, clinical management, eHealth, and healthcare system reform. The initiative prioritizes the global integration of patient (For the purposes of the Global PROMS Initiative, the term “patient” refers to the people with the disease (aka People with Multiple Sclerosis – pwMS): any individual with lived experience of the disease. People affected by the disease/Multiple Sclerosis: any individual or group that is affected by the disease: E.g., family members, caregivers will be also engaged as the other stakeholders in the initiative). insights into the management of MS care. It merges subjective PROs with objective clinical metrics, thereby addressing the complex variability of disease presentation and progression. Following the completion of its second phase, the initiative aims to help increasing the uptake of eHealth tools and passive PROs within research and clinical settings, affirming its unwavering dedication to the progressive refinement of MS care. Looking forward, the initiative is poised to continue enhancing global surveys, rethinking to the relevant statistical approaches in clinical trials, and cultivating a unified stance among ‘industry’, regulatory bodies and health policy making regarding the application of PROs in MS healthcare strategies.
Keywords:Multiple Sclerosis Progression, Patient Reported Outcomes, Patient Engagement, Personalized Medicine, Digital Health
Source:Frontiers in Neurology
ISSN:1664-2295
Publisher:Frontiers Media SA
Volume:15
Page Range:1407257
Date:2024
Official Publication:https://doi.org/10.3389/fneur.2024.1407257
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library